BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8839857)

  • 21. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia.
    Freedman MH; Cohen A; Grunberger T; Bunin N; Luddy RE; Saunders EF; Shahidi N; Lau A; Estrov Z
    Br J Haematol; 1992 Jan; 80(1):40-8. PubMed ID: 1311195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z; Talpaz M; Zipf TF; Kantarjian HM; Ku S; Ouspenskaia MV; Hirsch-Ginsberg C; Huh Y; Yee G; Kurzrock R
    J Cell Physiol; 1996 Mar; 166(3):618-30. PubMed ID: 8600166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interleukin-1 alpha also induces granulocyte-macrophage colony-stimulating factor in immature normal bone marrow cells.
    Bot FJ; Schipper P; Broeders L; Delwel R; Kaushansky K; Löwenberg B
    Blood; 1990 Jul; 76(2):307-11. PubMed ID: 1695108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth regulation of the AML-193 leukemic cell line: evidence for autocrine production of granulocyte-macrophage colony-stimulating factor (GM-CSF), and inhibition of GM-CSF-dependent cell proliferation by interleukin-1 (IL-1) and tumor necrosis factor (TNF alpha).
    Kindler V; Shields J; Ayer D; Mazzei GJ
    Int J Cancer; 1991 Feb; 47(3):450-4. PubMed ID: 1993554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and characterization of a new granulocyte-macrophage colony-stimulating factor-dependent and interleukin-3-dependent human acute myeloid leukemia cell line (GF-D8).
    Rambaldi A; Bettoni S; Tosi S; Giudici G; Schirò R; Borleri GM; Abbate M; Chiaffarino F; Colotta F; Barbui T
    Blood; 1993 Mar; 81(5):1376-83. PubMed ID: 8443395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-1 and interleukin-2 control granulocyte- and granulocyte-macrophage colony-stimulating factor gene expression and cell proliferation in cultured acute myeloblastic leukemia.
    Cozzolino F; Torcia M; Bettoni S; Aldinucci D; Burgio VL; Petti MC; Rubartelli A; Barbui T; Rambaldi A
    Int J Cancer; 1990 Nov; 46(5):902-7. PubMed ID: 1699903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of interferon-alpha (IFN) on the expression of interleukin 1-beta (IL-1), interleukin 6 (IL-6), granulocyte-macrophage colony-stimulating factor (GM-CSF) and tumor necrosis factor-alpha (TNF) in acute myeloid leukemia (AML) blasts.
    Sissolak G; Hoffbrand AV; Mehta AB; Ganeshaguru K
    Leukemia; 1992 Nov; 6(11):1155-60. PubMed ID: 1434798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells.
    Uemura Y; Kobayashi M; Nakata H; Harada R; Kubota T; Taguchi H
    Int J Cancer; 2004 May; 109(6):826-32. PubMed ID: 15027115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-6 and granulocyte-macrophage colony-stimulating factor are candidate growth factors for chronic myelomonocytic leukemia cells.
    Everson MP; Brown CB; Lilly MB
    Blood; 1989 Oct; 74(5):1472-6. PubMed ID: 2676012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human somatic PTPN11 mutations induce hematopoietic-cell hypersensitivity to granulocyte-macrophage colony-stimulating factor.
    Chan RJ; Leedy MB; Munugalavadla V; Voorhorst CS; Li Y; Yu M; Kapur R
    Blood; 2005 May; 105(9):3737-42. PubMed ID: 15644411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of monocyte-derived hemopoietic growth factors in the regulation of myeloproliferation in juvenile chronic myelogenous leukemia.
    Emanuel PD; Bates LJ; Zhu SW; Castleberry RP; Gualtieri RJ; Zuckerman KS
    Exp Hematol; 1991 Nov; 19(10):1017-24. PubMed ID: 1915702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interleukin 4 suppresses the spontaneous growth of chronic myelomonocytic leukemia cells.
    Akashi K; Shibuya T; Harada M; Takamatsu Y; Uike N; Eto T; Niho Y
    J Clin Invest; 1991 Jul; 88(1):223-30. PubMed ID: 2056118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia.
    Padron E; Painter JS; Kunigal S; Mailloux AW; McGraw K; McDaniel JM; Kim E; Bebbington C; Baer M; Yarranton G; Lancet J; Komrokji RS; Abdel-Wahab O; List AF; Epling-Burnette PK
    Blood; 2013 Jun; 121(25):5068-77. PubMed ID: 23632888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The GM-CSF analogue E21R induces apoptosis of normal and activated eosinophils.
    Iversen PO; Robinson D; Ying S; Meng Q; Kay AB; Clark-Lewis I; Lopez AF
    Am J Respir Crit Care Med; 1997 Nov; 156(5):1628-32. PubMed ID: 9372686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by 3H-thymidine assay.
    Tanaka M; Takahashi Y; Xu Y; Yoshida N; Yoshimi A; Villalobos IB; Hama A; Nishio N; Hidaka H; Wang Y; Yagasaki H; Kojima S
    Leuk Res; 2008 Jul; 32(7):1036-42. PubMed ID: 18164384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin (IL)-10, but not IL-4 or IL-13, inhibits cytokine production and growth in juvenile myelomonocytic leukemia cells.
    Iversen PO; Hart PH; Bonder CS; Lopez AF
    Cancer Res; 1997 Feb; 57(3):476-80. PubMed ID: 9012477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of SRC corrects GM-CSF hypersensitivity that underlies juvenile myelomonocytic leukemia.
    Bunda S; Kang MW; Sybingco SS; Weng J; Favre H; Shin DH; Irwin MS; Loh ML; Ohh M
    Cancer Res; 2013 Apr; 73(8):2540-50. PubMed ID: 23400592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of macrophages in the regulation of erythroid colony growth in vitro.
    Wang CQ; Udupa KB; Lipschitz DA
    Blood; 1992 Oct; 80(7):1702-9. PubMed ID: 1391939
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemopoietin-1 activity of interleukin-1 (IL-1) on acute myeloid leukemia colony-forming cells (AML-CFU) in vitro: IL-1 induces production of tumor necrosis factor-alpha which synergizes with IL-3 or granulocyte-macrophage colony-stimulating factor.
    Delwel R; van Buitenen C; Salem M; Oosterom R; Touw I; Löwenberg B
    Leukemia; 1990 Aug; 4(8):557-60. PubMed ID: 2201834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor-alpha-induced proliferation requires synthesis of granulocyte-macrophage colony-stimulating factor.
    Quentmeier H; Dirks WG; Fleckenstein D; Zaborski M; Drexler HG
    Exp Hematol; 2000 Sep; 28(9):1008-15. PubMed ID: 11008013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.